Sfoglia per Autore
Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
2021 Stutterheim, J; van der Sluis, I; de Lorenzo, P; Alten, J; Ancliffe, P; Attarbaschi, A; Brethon, B; Biondi, A; Campbell, M; Cazzaniga, G; Escherich, G; Ferster, A; Kotecha, R; Lausen, B; Li, C; Lo Nigro, L; Locatelli, F; Marschalek, R; Meyer, C; Schrappe, M; Stary, J; Vora, A; Zuna, J; van der Velden, V; Szczepanski, T; Valsecchi, M; Pieters, R
Pcr technology to identify minimal residual disease
2021 Cazzaniga, G; Songia, S; Biondi, A
HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia
2021 de Barrios, O; Galaras, A; Trincado, J; Azagra, A; Collazo, O; Meler, A; Agraz-Doblas, A; Bueno, C; Ballerini, P; Cazzaniga, G; Stam, R; Varela, I; De Lorenzo, P; Valsecchi, M; Hatzis, P; Menendez, P; Parra, M
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants
2021 Fazio, G; Bardini, M; De Lorenzo, P; Grioni, A; Quadri, M; Pedace, L; Corral Abascal, L; Palamini, S; Palmi, C; Buldini, B; Vinti, L; Parasole, R; Barisone, E; Zecca, M; Favre, C; Locatelli, F; Conter, V; Rizzari, C; Valsecchi, M; Biondi, A; Cazzaniga, G
Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia
2021 Ceppi, F; Rizzati, F; Colombini, A; Conter, V; Cazzaniga, G
Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study
2021 van der Velden, V; Bruggemann, M; Cazzaniga, G; Scheijen, B; Tops, B; Trka, J; Pal, K; Hanzelmann, S; Fazio, G; Songia, S; Langerak, A; Darzentas, N; van der Velden, V
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development
2021 Cazzola, A; Cazzaniga, G; Biondi, A; Meneveri, R; Brunelli, S; Azzoni, E
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)
2020 Pfeifer, H; Cazzaniga, G; van der Velden, V; Cayuela, J; Schafer, B; Spinelli, O; Akiki, S; Avigad, S; Bendit, I; Borg, K; Cave, H; Elia, L; Reshmi, S; Gerrard, G; Hayette, S; Hermanson, M; Juh, A; Jurcek, T; Chillon, M; Homburg, C; Martinelli, G; Kairisto, V; Lange, T; Lion, T; Mueller, M; Pane, F; Rai, L; Damm-Welk, C; Sacha, T; Schnittger, S; Touloumenidou, T; Valerhaugen, H; Vandenberghe, P; Zuna, J; Serve, H; Herrmann, E; Markovic, S; van Dongen, J; Ottmann, O
Dysregulation of NIPBL leads to impaired RUNX1 expression and haematopoietic defects
2020 Mazzola, M; Pezzotta, A; Fazio, G; Rigamonti, A; Bresciani, E; Gaudenzi, G; Pelleri, M; Saitta, C; Ferrari, L; Parma, M; Fumagalli, M; Biondi, A; Cazzaniga, G; Marozzi, A; Pistocchi, A
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis
2020 Isidro-Hernandez, M; Mayado, A; Casado-Garcia, A; Martinez-Cano, J; Palmi, C; Fazio, G; Orfao, A; Ribera, J; Ribera, J; Zamora, L; Raboso-Gallego, J; Blanco, O; Alonso-Lopez, D; De Las Rivas, J; Jimenez, R; Garcia Criado, F; Garcia Cenador, M; Ramirez-Orellana, M; Cazzaniga, G; Cobaleda, C; Vicente-Duenas, C; Sanchez-Garcia, I
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations
2020 Saettini, F; Fazio, G; Corti, P; Quadri, M; Bugarin, C; Gaipa, G; Penco, F; Moratto, D; Chiarini, M; Baronio, M; Gazzurelli, L; Imberti, L; Paghera, S; Giliani, S; Cazzaniga, G; Plebani, A; Badolato, R; Lougaris, V; Gattorno, M; Biondi, A
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche
2020 Beneforti, L; Dander, E; Bresolin, S; Bueno, C; Acunzo, D; Bertagna, M; Ford, A; Gentner, B; Kronnie, G; Vergani, P; Menendez, P; Biondi, A; D'Amico, G; Palmi, C; Cazzaniga, G
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial
2020 Attarbaschi, A; Mann, G; Zimmermann, M; Bader, P; Barisone, E; Basso, G; Biondi, A; Cario, G; Cazzaniga, G; Colombini, A; Flotho, C; Kuhlen, M; Lang, P; Lauten, M; Linderkamp, C; Locatelli, F; Lo Nigro, L; Moricke, A; Niggli, F; Panzer-Grumayer, R; Parasole, R; Peters, C; Caterina Putti, M; Rizzari, C; Suttorp, M; Valsecchi, M; Conter, V; Schrappe, M
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition
2020 Nucera, S; Fazio, G; Piazza, R; Rigamonti, S; Fontana, D; Gambacorti Passerini, C; Maitz, S; Rovelli, A; Biondi, A; Cazzaniga, G; Balduzzi, A
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with Ebf1-Pdgfrb fusion transcript
2020 Fazio, F; Barberi, W; Cazzaniga, G; Fazio, G; Messina, M; Della Starza, I; De Propris, M; Mancini, F; Mohamed, S; Del Giudice, I; Chiaretti, S; Moleti, M; Guarini, A; Foa, R; Testi, A
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities
2020 Magnani, C; Gaipa, G; Lussana, F; Belotti, D; Gritti, G; Napolitano, S; Matera, G; Cabiati, B; Buracchi, C; Borleri, G; Fazio, G; Zaninelli, S; Tettamanti, S; Cesana, S; Colombo, V; Quaroni, M; Cazzaniga, G; Rovelli, A; Biagi, E; Galimberti, S; Calabria, A; Benedicenti, F; Montini, E; Ferrari, S; Introna, M; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case
2020 D’Angiò, M; Fazio, G; Grioni, A; Palamini, S; Sala, S; Galbiati, M; Biondi, A; Balduzzi, A; Rizzari, C; Cazzaniga, G
Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemia
2020 Germano, G; Valsecchi, M; Buldini, B; Cazzaniga, G; Zanon, C; Silvestri, D; te Kronnie, G; Basso, G; Paganin, M
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
2020 Cario, G; Leoni, V; Conter, V; Attarbaschi, A; Zaliova, M; Sramkova, L; Cazzaniga, G; Fazio, G; Sutton, R; Elitzur, S; Izraeli, S; Lauten, M; Locatelli, F; Basso, G; Buldini, B; Bergmann, A; Lentes, J; Steinemann, D; Göhring, G; Schlegelberger, B; Haas, O; Schewe, D; Buchmann, S; Moericke, A; White, D; Revesz, T; Stanulla, M; Mann, G; Bodmer, N; Arad-Cohen, N; Zuna, J; Valsecchi, M; Zimmermann, M; Schrappe, M; Biondi, A
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia
2020 Schieck, M; Lentes, J; Thomay, K; Hofmann, W; Behrens, Y; Hagedorn, M; Ebersold, J; Davenport, C; Fazio, G; Moricke, A; Buchmann, S; Alten, J; Cario, G; Schrappe, M; Bergmann, A; Stanulla, M; Steinemann, D; Schlegelberger, B; Cazzaniga, G; Gohring, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile